JACOBS KENNETH M

Executive Chairman Kenneth Jacobs sells 189,004 shares (189.0K) for $9.1M at Lazard across 6 transactions.

Kenneth M Jacobs, Executive Chairman, executed 6 separate sales on September 3–4, 2024, totaling 189,004 shares for $9,093,609.95 at blended average price $48.11. This represents an 11.0% reduction in his holdings (from 1.71M to 1.52M shares). The stock has risen 9.1% over the prior 30 days and 26.3% over 90 days, and stands -3.6% from its 52-week high of $50.11. His cross-ticker track record shows 14 prior sells averaging +0.4% returns over 30 days and +21.9% over 90 days, with a well-timed rate of 0.00%, indicating his prior sales have generally not preceded price declines. The company reported full-year net income was negative despite the latest quarter showing $685.3M revenue and $49.9M net income, and year-over-year annual revenue declined 9.3%, with a P/E of 34.76 and market cap of $5.4B.

Lazard Executive Chairman Kenneth M. Jacobs sells 142,996 shares (34.1% of holdings) in 4 transactions for $7.2M at $50.02 average

Kenneth M. Jacobs, Executive Chairman of Lazard, executed 4 separate sales totaling 142,996 shares for $7,152,207.10 across August 23–26, 2024, at a blended average price of $50.02. This reduces his post-transaction holdings to 276,010 shares, a 34.1% reduction in stake. The sales occurred near the company's 52-week high (stock was -0.5% from the $49.88 peak) and represent the largest concentrated reduction in his observable holdings across the recent filing period. Company fundamentals show material headwinds: annual revenue declined 9.3% year-over-year, net income was negative over the full fiscal year, and the P/E of 35.69 reflects elevated valuation relative to profitability. His prior 5 trades at LAZ have shown mixed timing outcomes, with three showing positive 30-day returns (+5.8% and +10.8%) but only recent near-term price action as reference; post-trade price of $49.61 sits below the transaction average, providing no immediate favorable reversal signal for this specific filing.

Executive Chairman Jacobs sells 334,000 LAZ shares (50.3% of holdings) for $15.1M at $45.23

JACOBS KENNETH M, Executive Chairman of Lazard, Inc., filed a Form 4 disclosing 2 separate sales totaling 334,000 shares (334.0K shares) for $15,105,818.00 ($15.1M) on 2024-07-16, reducing his holdings from 664,279 shares to 330,279 shares. The sale occurred at $45.23 per share, near the 52-week high of $45.49, while the company faces a -9.3% annual revenue decline and reported negative full-year net income. This represents a substantial reduction—50.3% of pre-transaction holdings—executed while stock price momentum remains positive (30-day change: +19.5%; 90-day change: +18.7%), which contrasts with fundamental deterioration and prior timing outcomes at this ticker showing mixed results (-2.5% and -7.4% 30-day returns on recent June and May sales). The magnitude and timing of this divesting warrant investor scrutiny given the company's profitability headwinds and the executive's large stake reduction.

Executive Chairman Kenneth Jacobs sells 74,395 shares at $40.19 for $2,989,585.40 across 2 transactions; holds 457,279 shares post-sale.

Kenneth M. Jacobs, Executive Chairman of Lazard, executed 2 separate sales totaling 74,395 shares for $2,989,585.40 at a blended average price of $40.19 on 2024-07-09, reducing his holdings by 14.0% to 457,279 shares. The company faces mixed headwinds: revenue declined 9.3% year-over-year to $764,753,000.00 in the latest quarter, and the company was unprofitable over its most recent full fiscal year, despite current-quarter net income of $35,755,000.00. Jacobs's prior 5 trades at LAZ have shown modest negative returns (ranging -2.5% to -7.4% over 30 days), and his cross-ticker track record across 6 prior open-market sells averaged -5.0% 30-day returns. The stock is currently priced at $41.30, within 1.4% of its 52-week high and up 9.0% over 30 days, providing context on near-term momentum at the time of sale.